Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Light liquid paraffin is a highly refined mineral oil used as an emollient and skin protectant. It is the primary active ingredient in various dermatological products, such as Oilatum bath additive, where it is typically used at a 63% concentration. Its mechanism of action is physical; it forms an occlusive oily layer on the skin surface (stratum corneum), which prevents the evaporation of water (transepidermal water loss) and protects the skin from external irritants. This helps to hydrate the skin and manage symptoms of dry skin conditions like atopic dermatitis (eczema). While widely used in clinical practice, the phase 4 BATHE trial conducted by the University of Southampton found that adding bath emollients like light liquid paraffin to standard care provided no significant clinical benefit for children with atopic eczema.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on light liquid paraffin.